We are Genomics England and our vision is to create a world where everyone benefits from genomic healthcare. Join us every fortnight, where we cover everything from the latest in cutting-edge research to real-life stories from those affected by rare conditions and cancer. With thoughtful conversations, we take you behind the science. You can also tune in to our Genomics 101 explainer series which breaks down complex terms in under 10 minutes.
Episodes
Wednesday Jun 30, 2021
Helen Stokes-Lampard: Social prescribing and equity of access
Wednesday Jun 30, 2021
Wednesday Jun 30, 2021
“I see a future where people's whole genome will be known at a very early stage in their life, and we will be able to look at social factors and health inequalities and target help and support earlier for those in greater need. There will be huge logistical challenges, of course, but this technology isn't going away, this is here. It's how we apply it for the greatest good that matters.”
In this week’s episode of The G Word #sciencepodcast, our CEO Chris Wigley is joined by Helen Stokes-Lampard, Chair of the Academy of Medical Royal Colleges, Professor of GP Education at the University of Birmingham and Chair of the National Academy for Social Prescribing. Still a practising GP in Staffordshire, Helen is a huge advocate for mental health and has published several papers on women’s health and COVID-19.
Today, Helen talks about equity of access for patients, social prescribing and genomics. She also talks about her early career and her role as Chair of the Academy of Medical Royal Colleges.
Wednesday Jun 23, 2021
GenOMICC COVID-19 Study: Genomics and COVID-19
Wednesday Jun 23, 2021
Wednesday Jun 23, 2021
“Most of the genome is the same for everyone, but there are some places where you can have some variation. This variation, in this case between the people who had severe COVID-19 and the general population, highlights certain areas of the genome. Our job is to try to understand this region.”
In this week’s episode of The G Word #sciencepodcast, our CEO Chris Wigley is joined by Erola Pairo-Castineira, Suzi Walker, Athanasios Kousathanas and Dorota Pasko, all members of a collaborative effort between Genomics England and the GenOMICC consortium, led by the University of Edinburgh, to utilise genomics to better understand the human response to COVID-19.
The group talk about the publication of their findings in Nature, whole genome sequencing and 100K participants and their value as validation cohort. They also talk about CloudRE and their plans for the future.
Wednesday Jun 16, 2021
Dr Patrick Short: Revolutionising research
Wednesday Jun 16, 2021
Wednesday Jun 16, 2021
“It's a real power of some of the translational research that's being done that you can not only answer interesting, fundamental biological questions, but also impact people directly in the process.”
In this week’s episode of The G Word, our CEO Chris Wigley is joined by Dr Patrick Short, genomic researcher, bioinformatician and Co-Founder and CEO of Sano Genetics. For his PhD Patrick worked on the Deciphering Developmental Disorders (DDD) project, with his findings and methods being used in Genomics England's 100k analysis, and he has designed and taught courses on machine learning and data science at Cambridge Spark.
Today Patrick talks about the human aspect of research, precision medicine research and industry access to data. He also discusses the Deciphering Developmental Disorders project and his work with Sano Genetics.
Wednesday Jun 09, 2021
Matt Clifford: Machine learning and start-ups
Wednesday Jun 09, 2021
Wednesday Jun 09, 2021
“What can machine learning do? You know, it's like having a million interns. It's not they can do everything that your core business needs to be able to do, but there are some things they can do very well. And if you can have a million of them, then there are things you can achieve that would be almost impossible to achieve with human scale, with normal numbers of people.”
In this week’s episode of The G Word, Chris Wigley is joined by Matt Clifford, co-founder and CEO of Entrepreneur First and board member at Code for Girls. Matt holds degrees from Cambridge and MIT, where he was a Kennedy Scholar, and was awarded an MBE for services to business in the 2016 Queen’s Birthday Honours.
Today, Matt talks about successful start-ups, tech developments within genomics and the value of investors. He also discusses his work with Entrepreneur First and the power of machine learning.
Wednesday Jun 02, 2021
Christine Patch: The value of data
Wednesday Jun 02, 2021
Wednesday Jun 02, 2021
“Rare disease families really understand that data is important. Examining the family's genetics and bringing together groups of people with individual rare diseases to examine their genetics, and try and understand what's going on, has the potential to lead to both diagnosis and potential treatments. So they understand the power of data.”
In this week’s episode of The G Word, Chris Wigley is joined by Christine Patch, Clinical Lead for Genetic Counselling at Genomics England and Principal Staff Scientist in Genomic Counselling at the Society and Ethics Research group. An early advocate of genetic science, she became one of only 30 genetic nurses in the UK in 1989, and has subsequently worked as President of the European Society of Human Genetics and sat on the Human Genetics Commission.
Today, Christine talks about patient confidentiality and the code of duty, her early career in genetics and her role as Caldicott Guardian at Genomics England. She also discusses the intricacies of patient choice and the priorities for rare disease families.